Mitesco

Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.

LIVE QUOTE Original Report: Initiating Coverage...
Revive Therapeutics

Revive Therapeutics (RVVTF, RVV): Updates and News Archive.

Recent Headlines (See FDA Filing Submission at Bottom) LIVE QUOTE
CPRE Networks

Adding VYRE Network (CAPV) to the Watch List.

Look What We Found. Our First Internet Play in Ages, And It's a Doozy. We would categorize this...
omniq

OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.

Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share. Without disrupting legacy sales - CEO Shai...
Ehave, Psychedelic Stock Review

Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company

WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE What exactly is a favorite? First...

Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.

Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022. CITIUS NEWS ARCHIVE
Hea;thLynked, Biotech Stock Review

Up 191%, HealthLynked (HLYK) Reporting Decent Numbers.

Up as much as 417% from where we added it to the Watch List, the Company continues to report increasing revenues while...
@alanliverin

Bitcoin $30,000. Time to Bargain Hunt? Read This First.

The Bit Short: Inside Crypto’s Doomsday Machine Scary article on Tether/Bitcoin posted on...

Initiating Coverage on Society Pass (SOPA).

Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley
Draganfly

Draganfly (DFLYF) Holds ‘Pole Position’ in Race for Drone Supremacy After Chinese Barred from...

STREETWISE REPORTS - March 3, 2020 The company establishes a toehold with U.S....

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...